Microencapsulation and electrostatic processing method
First Claim
1. A method for preparing a microcapsule comprising the steps of:
- formulating a primary solution;
formulating a secondary solution;
adding said primary solution to a first chamber;
adding said secondary solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier such that said secondary solution forms an interface with said primary solution at said porous barrier; and
allowing said primary and secondary solutions to become quiescent; and
moving said interface away from said porous barrier; and
allowing microcapsules to form; and
isolating said microcapsules by filtration through a porous barrier.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods are provided for forming spherical multilamellar microcapsules having alternating hydrophilic and hydrophobic liquid layers, surrounded by flexible, semi-permeable hydrophobic or hydrophilic outer membranes which can be tailored specifically to control the diffusion rate. The methods of the invention rely on low shear mixing and liquid-liquid diffusion process and are particularly well suited for forming microcapsules containing both hydrophilic and hydrophobic drugs. These methods can be carried out in the absence of gravity and do not rely on density-driven phase separation, mechanical mixing or solvent evaporation phases. The methods include the process of forming, washing and filtering microcapsules. In addition, the methods contemplate coating microcapsules with ancillary coatings using an electrostatic field and free fluid electrophoresis of the microcapsules. The microcapsules produced by such methods are particularly useful in the delivery of pharmaceutical compositions.
61 Citations
52 Claims
-
1. A method for preparing a microcapsule comprising the steps of:
- formulating a primary solution;
formulating a secondary solution;
adding said primary solution to a first chamber;
adding said secondary solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier such that said secondary solution forms an interface with said primary solution at said porous barrier; and
allowing said primary and secondary solutions to become quiescent; and
moving said interface away from said porous barrier; and
allowing microcapsules to form; and
isolating said microcapsules by filtration through a porous barrier. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 38, 40, 50)
- formulating a primary solution;
-
37. A method for preparing a microcapsule comprising the steps of:
- formulating a primary solution;
formulating a secondary solution adding said secondary solution to a first chamber;
adding said primary solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier, said primary solution being added to said second chamber so as to create an interface with said secondary solution at said porous barrier;
allowing said primary and secondary solutions to become quiescent;
moving said interface away from said porous barrier and into said second chamber;
allowing microcapsules to form;
isolating said microcapsules by filtration through a porous barrier;
washing said microcapsules by introducing a solution into the chamber containing said microcapsules;
introducing a coating solution into said first chamber; and
applying an electric field in the range of approximately 1 to 500 volts/cm into said first chamber.
- formulating a primary solution;
-
39. A microcapsule produced by a method comprising the steps of:
- adding a first solution to a first chamber; and
adding a second solution that is immiscible with said first solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier, said second solution being added to said second chamber so as to create an interface with said first solution at said porous barrier;
allowing said first and second solutions to become quiescent and moving said interface away from said porous barrier; and
allowing microcapsules to form; and
isolating said microcapsules by filtration through a porous barrier. - View Dependent Claims (41, 42, 43, 44, 45, 46, 47)
- adding a first solution to a first chamber; and
-
48. A microcapsule prepared by formulating a primary solution;
- formulating a secondary solution that is hydrophilic relative to said primary solution;
adding said secondary solution to a first chamber; and
adding said primary solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier that is hydrophobic if said secondary solution is hydrophobic relative to said primary solution or hydrophilic if said secondary solution is hydrophilic relative to said primary solution, said primary solution being added to said second chamber so as to create an interface with said secondary solution at said porous barrier;
allowing said primary and secondary solutions to become quiescent;
moving said interface away from said porous barrier and into said first chamber;
allowing microcapsules to form;
isolating said microcapsules by filtration through a porous barrier;
formulating a wash solution;
washing said microcapsules by introducing said wash solution into the chamber containing said microcapsules;
formulating a coating solution;
adding said coating solution to said microcapsules; and
generating coated microcapsules. - View Dependent Claims (49)
- formulating a secondary solution that is hydrophilic relative to said primary solution;
-
51. A microcapsule prepared by formulating a primary solution by preparing a mixture containing 1 mg/ml Reglan, 1% polyethylene glycol-400, 5% dextran-40, 1% Tween 80, 0.5% polyvinyl pyrrolidone, 0.05% Cy-3 fluorescent dye;
- formulating a secondary solution by preparing a mixture containing 5% glycerol monostearate, 92% isopropyl alcohol, 3% iodinated poppy seed oil, 2% water, 1.5% hexanol, 1.5% heptanol adding said secondary solution to a first chamber; and
adding said primary solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier, said primary solution being added to said second chamber so as to create an interface with said secondary solution at said porous barrier;
allowing said primary and secondary solutions to become quiescent;
moving said interface away from said porous barrier and into said first chamber;
allowing microcapsules to form;
applying an electric field of 14 volts/cm to the microcapsule formation chamber for 1 minute and then reversing the polarity of the electrodes and applying an electric field of 14 volts/cm for a period of 30 seconds;
isolating said microcapsules by filtration through a porous barrier;
washing the coated microcapsules with water.
- formulating a secondary solution by preparing a mixture containing 5% glycerol monostearate, 92% isopropyl alcohol, 3% iodinated poppy seed oil, 2% water, 1.5% hexanol, 1.5% heptanol adding said secondary solution to a first chamber; and
-
52. A microcapsule having a diameter of over 160 microns prepared by formulating a primary solution by preparing a mixture containing 2.5% myverol 1804, 2.5% vitamin E succinate, 88% isopropanol, 5% iodinated poppy seed oil, 2% water, 2.5% hexanol and 2.5% heptanol;
- formulating a secondary solution by preparing a mixture containing 2% of a solution containing fluorocein isothiocyanate, 1% polyethylene glycol 4000, 5% dextran-40, 1% ethoxylated (20) sorbitan monooleate;
adding said secondary solution to a first chamber;
adding said primary solution to a second chamber that is adjacent to said first chamber and separated from said first chamber by a porous barrier, said primary solution being added to said second chamber so as to create an interface with said secondary solution at said porous barrier;
allowing said primary and said secondary solutions to become quiescent; and
moving said interface away from said porous barrier and into said second chamber; and
allowing microcapsules to form for one hour.
- formulating a secondary solution by preparing a mixture containing 2% of a solution containing fluorocein isothiocyanate, 1% polyethylene glycol 4000, 5% dextran-40, 1% ethoxylated (20) sorbitan monooleate;
Specification